{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:33:45Z","timestamp":1788870825991,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ajem.2025.10.033","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:27:38Z","timestamp":1760743658000},"page":"313-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Assessing the Cardiac Safety of a Multimodal Protocol for \u2018Tranq Dope\u2019 Withdrawal: A Retrospective QTc Analysis"],"prefix":"10.1016","volume":"99","author":[{"given":"Kory S.","family":"London","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Deschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Graver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Figaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Rucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna R.","family":"Hoopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kahoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Pavri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ajem.2025.10.033_bb0005","first-page":"503","article-title":"Notes from the field: Xylazine detection and involvement in drug overdoses\u2014United States, 2019\u20132021","volume":"71","author":"Kariisa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.ajem.2025.10.033_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35857","article-title":"Precipitated withdrawal in the era of street fentanyl\u2014the important thing is to not stop questioning","volume":"7","author":"Soares","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.ajem.2025.10.033_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35895","article-title":"Buprenorphine-precipitated withdrawal among hospitalized patients using fentanyl","volume":"7","author":"Thakrar","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajem.2025.10.033_bb0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajem.2024.08.036","article-title":"Tranq dope: characterization of an ED cohort treated with a novel opioid withdrawal protocol in the era of fentanyl\/xylazine","volume":"85","author":"London","year":"2024","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2025.10.033_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/ajad.70051","article-title":"Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review","author":"Owusu-Antwi","year":"2025","journal-title":"Am J Addict"},{"issue":"15","key":"10.1016\/j.ajem.2025.10.033_bb0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.15585\/mmwr.mm7415a2","article-title":"Notes from the field: suspected medetomidine withdrawal syndrome among fentanyl-exposed patients\u2014Philadelphia, Pennsylvania, September 2024\u2013January 2025","volume":"74","author":"Huo","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.ajem.2025.10.033_bb0035","first-page":"13","article-title":"Decreased effectiveness of a novel opioid withdrawal protocol following the emergence of medetomidine as a fentanyl adulterant","volume":"5","author":"London","year":"2025","journal-title":"Biomedicines"},{"issue":"14","key":"10.1016\/j.ajem.2025.10.033_bb0040","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.3390\/ijms26146715","article-title":"Bio-chemical identification and clinical description of medetomidine exposure in people who use fentanyl in Philadelphia, PA","volume":"26","author":"Durney","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"00","key":"10.1016\/j.ajem.2025.10.033_bb0045","first-page":"1","article-title":"Severe fentanyl withdrawal associated with me-detomidine adulteration: a multicenter study from Philadelphia","volume":"00","author":"London","year":"2025","journal-title":"PA J Addict Med"},{"key":"10.1016\/j.ajem.2025.10.033_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2023.02.060","article-title":"Contribution of cytokine-mediated prolongation of QTc interval to the multi-hit theory of torsade de pointes","volume":"655","author":"Cupelli","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.ajem.2025.10.033_bb0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.md.0000085057.63483.9b","article-title":"Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors","volume":"82","author":"Zeltser","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.ajem.2025.10.033_bb0060","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2146\/ajhp070392","article-title":"Methadone-associated QT interval prolongation and torsades de pointes","volume":"66","author":"Stringer","year":"2009","journal-title":"Am J Health-Syst Pharm"},{"issue":"11","key":"10.1016\/j.ajem.2025.10.033_bb0065","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2146\/ajhp060505","article-title":"Evidence-based review of the black-box warning for droperidol","volume":"64","author":"Jackson","year":"2007","journal-title":"Am J Health-Syst Pharm"},{"issue":"3","key":"10.1016\/j.ajem.2025.10.033_bb0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.annemergmed.2015.03.016","article-title":"The safety and effectiveness of droperidol for sedation of acute behavioral disturbance in the emergency department","volume":"66","author":"Calver","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2025.10.033_bb0075","first-page":"1","article-title":"Drug Droperidol (marketed as Inapsine) information","year":"2001","journal-title":"FDA Drug Safety Commun"},{"issue":"1","key":"10.1016\/j.ajem.2025.10.033_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jemermed.2014.12.024","article-title":"American Academy of emergency medicine position statement: safety of droperidol use in the emergency department","volume":"49","author":"Perkins","year":"2015","journal-title":"J Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2025.10.033_bb0085","first-page":"293","article-title":"QTc interval prolongation with droperidol use in the ED: does it matter?","volume":"29","author":"Martel","year":"2011","journal-title":"Am J Emerg Med"},{"issue":"9209","key":"10.1016\/j.ajem.2025.10.033_bb0090","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajem.2025.10.033_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1074248410395020","article-title":"Tizanidine (Zanaflex), a muscle relaxant that may prolong the QT interval by blocking IKr","volume":"17","author":"Kaddar","year":"2012","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.ajem.2025.10.033_bb0100","first-page":"934","article-title":"Reports of torsade de pointes with the use of guanfacine","volume":"16","author":"de la Pe\u00f1a","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.ajem.2025.10.033_bb0105","first-page":"301","article-title":"A thorough QT study of guanfacine","volume":"53","author":"Martin","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ajem.2025.10.033_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0970-9185.173335","article-title":"Ketamine-induced QTc interval prolongation","volume":"33","author":"Singh","year":"2017","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"10.1016\/j.ajem.2025.10.033_bb0115","author":"About CredibleMeds\u00ae: Crediblemeds [Internet]"},{"issue":"6","key":"10.1016\/j.ajem.2025.10.033_bb0120","article-title":"QTc interval screening for cardiac risk in methadone treatment of opioid dependence","author":"Pani","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ajem.2025.10.033_bb0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J Psychoactive Drugs"},{"issue":"10","key":"10.1016\/j.ajem.2025.10.033_bb0130","first-page":"e241","article-title":"AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval","volume":"119","author":"Rautaharju","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajem.2025.10.033_bb0135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijcard.2014.04.133","article-title":"New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limits","volume":"174","author":"Rautaharju","year":"2014","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.ajem.2025.10.033_bb0140","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1113\/JP270526","article-title":"Predicting drug-induced QT prolongation and torsades de pointes","volume":"594","author":"Roden","year":"2016","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.ajem.2025.10.033_bb0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2042098612454283","article-title":"Drug-induced QT interval prolongation: mechanisms and clinical management","volume":"3","author":"Nachimuthu","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.ajem.2025.10.033_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf282","article-title":"Illicit stimulants and ventricular arrhythmias: a longitudinal cohort study","author":"Noubiap","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajem.2025.10.033_bb0155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcrc.2019.09.014","article-title":"The incidence, predictors and outcomes of QTc prolongation in critically ill patients","volume":"54","author":"Russell","year":"2019","journal-title":"J Crit Care"},{"issue":"2","key":"10.1016\/j.ajem.2025.10.033_bb0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/ADM.0000000000001423","article-title":"Withdrawal signs and symptoms among patients positive for fentanyl with and without xylazine","volume":"19","author":"Alexander","year":"2025","journal-title":"J Addict Med"},{"issue":"2","key":"10.1016\/j.ajem.2025.10.033_bb0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/AC.70.2.3073513","article-title":"Underestimated and unreported prolonged QTc by automated ECG analysis in patients on methadone: can we rely on computer reading?","volume":"70","author":"Talebi","year":"2015","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ajem.2025.10.033_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-5-29","article-title":"Accuracy of popular automatic QT interval algorithms assessed by a \u201cgold standard\u201d and comparison with a novel method: computer simulation study","volume":"5","author":"Hunt","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ajem.2025.10.033_bb0175","article-title":"Rates of hospitalization among people with diagnoses of opioid use. Substance use Philly","year":"2024","journal-title":"Substance Use Philly"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675725006850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675725006850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T21:40:16Z","timestamp":1770154816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675725006850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"alternative-id":["S0735675725006850"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2025.10.033","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the Cardiac Safety of a Multimodal Protocol for \u2018Tranq Dope\u2019 Withdrawal: A Retrospective QTc Analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2025.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}